Home
Argenx

Argenx Market Share Analysis for March 2026

reaching patients through immunology innovation

Health > Biotechnology and Pharmaceuticals

Domainargenx.com

Year Founded2008

Employees1001 - 5000

Annual Revenue$500M - $1B

Argenx

Argenx (including company regionals)

argenx.com

See more website traffic and engagement information

Argenx Revenue up to March 2026 is 500M - 1B

revenue generated by Argenx top domains

Argenx top domains revenue over 3 years

Revenue for Argenx top domains

argenx.com500M - 1B

See more with Sales Intelligence

Total visits to Argenx's top domains

Understand Argenx market share and potential market reach.

Total visits last 3 months

Subsidiaries Breakdown

argenx.com66.6K

See more with Sales Intelligence

Avg. visit duration in Argenx's top domains

Analyze Argenx engagement metrics.

Average visit duration last 3 months

Subsidiaries Breakdown

argenx.com00:00:44

See more with Sales Intelligence

Avg. pageviews on Argenx's top domains

See how Argenx keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

Subsidiaries Breakdown

argenx.com1.91

See more with Sales Intelligence

Argenx top competitors by domain

Top similar sites in March 2026, ranked by their affinity

immunovant.comCompany NameImmunovantEmployees201 - 500HQUnited States, New York, New York CityAnnual revenue$5M - $10MTotal visits6.7KHealth > Biotechnology and Pharmaceuticals

Top technologies used by Argenx

These are the website technologies, by industry, used by Argenx top domains

Advertising (7)

DoubleClick

Content Management System (4)

Drupal

Social (4)

Instagram

Widget (4)

reCAPTCHA

More Technologies

12

See all

News & Signals from Argenx

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsArgenx recognized as top large-cap biotech picks for on Jan 1st '26.Investing.com - Bank of America has reaffirmed Argenx (NASDAQ:ARGX) and Vertex Pharmaceuticals (NASDAQ:VRTX) as its top large-cap biotech picks for 2026, with price targets of $1,013 and $598, respectively.

NewsFolia Health, Inc. partners with Argenx.BOSTON, April 07, 2026 (GLOBE NEWSWIRE) - Folia Health today announced a collaboration with argenx to launch a first-of-its-kind, at-home observational real-world evidence initiative supporting individuals living with chronic inflammatory demyelinating polyradiculoneuropathy (CIDP).

NewsArgenx will attend event Annual General Meeting on May 6th '26.Amsterdam, the Netherlands - argenx SE (Euronext & Nasdaq: ARGX), a global immunology company committed to improving the lives of people suffering from severe autoimmune diseases, today announced that the Annual General Meeting of shareholders will be held at 13:00 CET on Wednesday, May 6, 2026 at the Hilton Amsterdam Schiphol at Schiphol Boulevard 701, 1118 BN Schiphol, the Netherlands.